Bangkok, Thailand 11 August 2026 Madame Biosciences Public Company Limited (MADAME) reported a continued improvement in operating performance for the second quarter of 2026, driven by the rapid expansion of its Madame Louise Skincare and Wellness business and the completion of the Company's capital restructuring during the quarter. Revenue from sales reached Baht 432.41 million, up 14.56% year-on-year. Gross profit rose 31.36% to Baht 141.82 million, with the gross profit margin improving from
"Madame Biosciences" โชว์ผลงานไตรมาส 2 เติบโตแข็งแกร่ง แบรนด์ "มาดามหลุยส์" พาสวยและรวยอย่างโดดเด่น
—
บริษัท มาดาม ไบโอไซเอนซ์ จำกัด (มหาชน) หรือ MADAME ร...
China's National Medical Imaging AI Contest Extends Innovation Invitation to ASEAN
—
The National Medical Insurance Imaging AI Recognition Competition Org...